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Abstract
Background—The Sweet Taste Test (STT) measures hedonic responses to sweet tastes and has
been linked to both alcoholism and to a family history of alcoholism. However, STT response
profiles in unipolar major depressive disorder (MDD), a disorder characterized by anhedonia, have
been minimally investigated.
Methods—Twelve adults with and 15 adults without MDD participated in two identical STT
assessments separated by approximately 12 weeks. Between assessments, MDD outpatients
received Behavioral Activation Therapy for Depression, a psychotherapy modality designed to
increase engagement with rewarding stimuli and reduce avoidance behaviors. Primary dependent
measures included sensitivity to sucrose, hedonic response to sucrose, and designation as a Sweet
Liker or Sweet Disliker.
Results—75% of adults with MDD were treatment responders. There were no significant
differences in STT response profiles between groups overall or at either timepoint. Furthermore,
STT profiles of MDD participants did not differ after psychotherapy, relative to baseline.
Conclusions—Findings suggest that although anhedonia is a symptom of MDD, the disorder is
not characterized by altered responses to sweet tastes. Implications and future directions are
discussed.
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Anhedonia, the diminished capacity to experience pleasurable events as such, is a defining
feature of unipolar major depressive disorder (MDD) [1]. MDD is characterized by
diminished pleasure in a number of contexts, including (a) attenuated subjective responses to
pleasant images [2–5]; (b) aberrant psychophysiological responses to pleasurable images
[6,7]; and (c) functional neural deficits in brain regions mediating reward processing [8–10].
However, there are relatively few studies that assess sensory responses to putatively
pleasurable stimuli. Such studies are critical in order to understand the boundary conditions
of pleasure deficits in MDD.
The scope of the word “anhedonia” implies a complete lack of pleasure, including sensory
pleasures (e.g., touch, taste, smell). However, the total absence of pleasurable responses is a
rare state [11]. Further, is not entirely clear whether individuals with MDD truly lack the
capacity for sensory pleasures, or rather undervalue the cognitive impact of rewards while
simultaneously preserving a capacity for sensory pleasure. In other words, despite the
converging neuroimaging evidence that MDD is characterized by decreased activity in
reward-related brain regions in response to pleasurable stimuli [12,13,9,14] and despite
linkages between the neurobiological substrates of responses to sweet tastes [i.e., the nucleus
accumbens; 15,16] and neurofunctional correlates of anhedonia in MDD [8,17], sensory
responses to pleasurable stimuli have rarely been assessed in MDD. To partially address this
unanswered question, in the present study, we examined responses to sweet tastes via the
Sweet Taste test [STT; 18] in adult outpatients with MDD before and after psychotherapy
and compared response profiles to those of nondepressed control participants also assessed
at two points in time.
Hedonic response to sweet taste is a stable trait in nonclinical contexts [19–21] and is
resistant to different metabolic manipulations, including food intake, dieting, and overnight
fasting [22]. Cravings for sweet foods and elevated hedonic responses to sweet tastes have
been reported amongst patients with a range of psychiatric disorders, including seasonal
affective disorder and binge eating disorder [see 18 for a review]. In particular, the STT has
emerged as an indicator of risk for alcohol use disorders: “Sweet-likers” (i.e., those who
prefer the highest STT sucrose concentration) are more likely to have alcoholism and/or a
paternal history of alcoholism than “Sweet-dislikers” [19,23].
There have been three published studies to date of responses to sweet tastes in MDD. Berlin
and colleagues [24] reported higher sweet taste perception thresholds but equivalent hedonic
responses to sucrose in adults with and without MDD. Kazes and colleagues [25] reported a
preference for sweet foods in MDD that did not change with antidepressant treatment, but
did not formally assess responses to varying concentrations of sweet solutions. Finally,
Amsterdam and colleagues [26] reported similar intensity and pleasantness ratings to lower
sweet concentrations in MDD relative to a control group, but found that individuals with
MDD gave relatively lower intensity and higher pleasantness ratings to higher sucrose
concentrations. No study to date has examined responses to sweet tastes in individuals with
MDD using the STT, a measure that yields three types of information about response to
sweet solutions: sensitivity to sucrose, hedonic response to sucrose, and sweet liking/sweet-
disliking.
Hypotheses were informed by the findings of Berlin and colleagues [24] and the pattern of
findings of Amsterdam and colleagues [26] to lower sweet concentrations: we hypothesized
that MDD would be characterized by blunted hedonic responses to sweet tastes across the
three STT metrics examined. Based on findings described above that sweet taste preference
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is a stable trait [19] and that sweet preference is maintained following treatment for MDD
[25], we hypothesized that that psychotherapy would not impact STT profiles in MDD.
Materials and Method
Participants
Sample characteristics have been reported elsewhere [10]. All participants received a
Structured Clinical Interview for DSM-IV [SCID; 27]. The MDD group met DSM-IV
criteria for a current episode of MDD, no other current Axis I disorder other than dysthymia,
and scored 15 or above on the Hamilton Rating Scale for Depression [HAM-D, 28]. The
control group scored 6 or lower on the HAM-D and did not meet criteria for a current Axis I
disorder or a current/lifetime mood disorder. Exclusion criteria included: 1) bipolar or
psychotic disorder, 2) comorbid Axis I diagnosis, 3) active suicidal ideation, 4) evidence of
organicity, 5) verbal IQ below 70, 6) history of neurological injury or disease, and 7) use of
psychoactive medications including antidepressants. Written informed consent was obtained
and participants were paid $10 for each STT session.
Sixteen MDD and 15 control participants enrolled. Four MDD participants did not return for
the Time 2 STT session, resulting in 12 depressed (6 females, average age 39.0 ± 10.4 years)
and 15 control (9 females, average age 30.8 ± 9.6 years) participants with data at both
timepoints. Groups did not differ in age, estimated verbal IQ [29] (MDD=112.8,
Control=117.7), or gender distribution, χ2 (1) = .99 p >0.32.
Brief Behavioral Activation Treatment for Depression (BATD)
The MDD group received an average of 11.4 (SD=2.0) weekly sessions of Brief Behavioral
Activation Treatment for Depression (BATD). BATD is a validated psychotherapy method
designed to increase engagement with rewarding behaviors and reduce avoidance behaviors
[30,31].
Sweet Taste Test (STT)
The STT has been described previously [18]. Briefly, each of five concentrations of sucrose
solution (0.05, 0.10, 0.21, 0.42, and 0.83 M) was presented five times in random order, for a
total of 25 samples per session (Coca-Cola Classic is a 0.33 M sugar solution). Participants
were instructed to sip the solution, swish it around in their mouths, and spit it out. They then
rated the solution, rinsed their mouth with distilled water, and proceeded to the next
solution. Each participant was asked to rate intensity (“How sweet was the taste?”) and
pleasantness (“How much do you like the taste?”) on 200-mm analog scales. Time 1 STT’s
were administered on the same day as the SCID, and the two STT assessments were
separated by 102.5 (SD=10.1) days for the nondepressed group and by 102.2 (SD=15.4)
days for the MDD group.
Consistent with previous studies of STT profiles [18,19], three primary STT dependent
measures were examined: (1) Hedonic response was the slope of pleasantness ratings: a
natural logarithm transformation was applied to pleasantness scores, and then the slope of a
linear regression line of pleasantness scores over the five concentrations was estimated.
Higher slopes denote greater pleasantness ratings as sweet concentrations increased. (2)
Sensitivity to sucrose was the slope of intensity ratings: a natural logarithm transformation
was applied to sensitivity scores, and then the slope of a linear regression line of sensitivity
scores over the five concentrations was estimated. Higher slopes denote greater intensity
ratings as sweet concentrations increased. (3) Sweet liking (SL) was defined as preferring the
highest concentration, 0.83 M, and sweet disliking (SDL) was defined as preferring one of
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the lower concentrations (0.05, 0.10, 0.21 or 0.42 M). The designation as SL or SDL as been
suggested as a putative probe of brain opioid function [32].
Statistical Analyses
To examine Group (MDD, Nondepressed) and Time (Time 1, Time 2) effects on hedonic
responses and sensitivity to sucrose, slopes were analyzed by a mixed model via SAS Proc
GLIMMIX [33] which accounts for the clustering attributable to these two repeated
measures, followed by independent samples t-tests at both timepoints. To examine sweet
liking (SL) status, chi-square tests were conducted, McNemar’s test was used to assess the
overall significance of the difference between two correlated proportions (i.e., early and late
sucrose concentration tests) [35], whereas generalized linear mixed models [33] were used
to assess if the difference in the correlated proportions was different between MDD and
Nondepressed groups.
We also report Cohen’s d effect sizes at each time point for pairwise contrast of the
difference between diagnostic groups for continuous measures, where an effect size of 0.2 is
small, 0.5 is medium, 0.8 is large, and 1.2 is very large [37]. For designation of SL status,
effect size was measured using odds ratios, where 1.5 is a small effect, 2.5 is a medium
effect, 4 is a large effect, and an 10 is a very large effect [36].
Results
Psychotherapy Outcomes
As reported in Dichter et al. (2009), within the MDD group HAM-D scores changed from
23.8 (SD=2.3) at Time 1 to 8.7 (SD=9.4) at Time 2 (p<.003). 75% of participants were
responders (i.e., Time 2 HAM-D scores of ≤ 6), and 83% were partial responders (i.e., Time
2 HAM-D scores of ≤ 10). Analyses below include all MDD participants (n=12); results are
nearly identical when including only psychotherapy responders (n=9).
Hedonic response
The mixed model Group X Time interaction test on hedonic responses was not significant,
F(1,25)=0.001, p=0.98. Pleasantness slopes at Time 1 were 0.103 ± 0.592 and 0.133 ± 0.884
for the nondepressed and MDD groups, respectively, a nonsignificant difference, t(25)=
−0.11, p=0.92, corresponding to a Cohen’s d[37] effect size of d=0.04 (less than a small
effect). Pleasantness liking slopes at Time 2 were 0.073 ± 0.673 and 0.106 ± 0.850 for the
nondepressed and MDD groups, respectively, a nonsignificant difference, t(25)=−0.11,
p=0.91, corresponding to a Cohen’s d[37] effect size of d=0.05 (less than a small effect).
Time 1 and 2 slopes were highly correlated, r=0.90 and 0.93 for nondepressed and MDD
groups, respectively.
Sensitivity to sucrose
The mixed model Group X Time interaction test on sensitivity slopes was not significant,
F(1,25)=2.38, p=0.14. Sensitivity slopes at Time 1 were −1.23 (SD= 0.31) and −1.40
(SD=0.35) for the nondepressed and MDD groups, respectively, a nonsignificant difference,
t(25)=1.31, p=0.20, corresponding to a Cohen’s d[37] effect size of d=0.51 (a medium
effect). Sensitivity slopes at Time 2 were −1.40 (SD= 0.30) and −1.25 (SD=0.53) for the
nondepressed and MDD groups, respectively, a nonsignificant difference, t1(16)=−0.86,
p=0.40, corresponding to a Cohen’s d[37] effect size of d=0. 37 (a small-to-medium effect).
1Degrees of freedom determined through Satterthwaite approximation.
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The Time effect on the designation as SL or SDL was not significant, as assessed through
McNemar’s test, χ2(1) = 0.33, p=0.56, with 12.5% as SL at Time 1 (4/32) versus 6.3%
(2/32) as SL at Time 2, corresponding to effect size odds ratios of 1.14 at Time 1 and 1.26 at
Time 2, both corresponding to lower than small effect sizes. The Group X Time interaction
on the designation as SL or SDL was not significant, as assessed through generalized linear
mixed model test, F(1, 25)=0.03, p=0.86. At Time 1, 11.8% and 13.3% of nondepressed and
MDD participants, respectively, were categorized as SL, a nonsignificant difference,
χ2(1)=0.02, p=0.89. At Time 2, 6.7% and 8.3% of nondepressed and MDD participants,
respectively, were categorized as SL, a nonsignificant difference, χ2 (1)=0.03, p=0.87).
Discussion
The goal of the present study was to assess whether MDD, a disorder characterized by
anhedonia, [1] is associated with altered responses to sweet tastes measured via three SST
metrics: sensitivity to sucrose, hedonic response, and designation as sweet-liking or sweet-
disliking. The STT is a validated assay of sweet reactivity that predicts alcohol abuse
disorder, seasonal affective disorder, and binge eating disorder [see 18 for a review].
Contrary to predictions, groups did not differ on the three measures of STT responsivity.
Further, despite robust response to psychotherapy, there was no evidence of differential STT
change in the MDD group after psychotherapy, relative to repeated STT assessment in the
control group. These results suggest that MDD may not impact responses to sweet tastes.
The present findings confirm and extend the finds of Berlin and colleagues [24] who
reported equivalent hedonic responses to a range of sucrose solutions in MDD and stand in
contrast to the portions of findings of Amsterdam and colleagues [26] who found evidence
of blunted intensity ratings and higher pleasure ratings to higher concentrations of sweet
solutions in MDD. The present data also indicate that adults with MDD have similar hedonic
sensitivity slopes and similar sweet liking/disliking status profiles. Though the precise
reasons for differences between the present findings and the results of Amsterdam and
colleagues [26] is unclear, the present study is the first to report simultaneously of hedonic
response to sucrose, sensitivity to sucrose, and sweet liking/disliking status profiles in
individuals with MDD in a treatment context.
The STT has emerged as an indicator of risk for alcohol use disorders: “Sweet-likers” (i.e.,
those who prefer the highest STT sucrose concentration) are more likely to have alcoholism
and/or a paternal history of alcoholism than “Sweet-dislikers” [19,23]. Amsterdam and
colleagues [26] reported similar intensity and pleasantness ratings to lower sweet
concentrations in MDD relative to a control group, but found that individuals with MDD
gave relatively lower intensity and higher pleasantness ratings to higher sucrose
concentrations. Kazes end colleagues [25] reported a preference for sweets in MDD that did
not change with antidepressant treatment (despite increased appetite). Finally, Berlin and
colleagues [24] reported equivalent hedonic responses to sucrose in adults with and without
MDD. However, no study to date has examined hedonic sensitivity slopes nor the
categorical characterization as a “sweet-liker” or “sweet-disliker” [18].
A number of studies have indicated that MDD is characterized by disruptions of brain
activation patterns in orbitofrontal, insular, and other limbic regions in response to images
and monetary incentives [12,13,9,14]. The present findings raise the possibility that MDD
may impair cognitive evaluations of putatively pleasurable stimuli, yet leave intact more
basic capacity for pleasure reactions. This pattern of findings raises the possibility that
cognitive interventions may not need to focus on the sensory feeling of a pleasurable
stimulus, but rather on the downstream cognitive mediation of response to such stimuli.
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Response to sweet tastes are mediated by the nucleus accumbens [15,16], the same region
that is hypoactive to rewards in MDD [8,17]. Additionally, orbital frontal networks both
respond to gustatory information and regulate mood [38]. However, brain imaging studies of
reward processing in MDD have assessed responses to monetary incentives or responses to
pleasant pictures [13,12], and future neuroimaging studies that assess accumbens response to
sweet tastes are needed. Nevertheless, the present findings suggest that anhedonia in MDD
may not in fact extend to subjective responses to sweet tastes. This conceptualization is
consistent with theories of anhedonia in MDD that suggest that this symptom domain may
not reflect a global insensitivity to pleasure but rather reflect a tendency to undervalue
rewards [39].
We note that caution is warranted in interpreting our findings that groups did not differ
statistically on all STT measures, which in this context is essentially confirmation of the null
hypotheses that groups would not differ. Formal validation of the null hypothesis would
require a bioequivalence analysis, a method to determine whether groups are sufficiently
near each other to be considered equivalent [40]. However, the sample sizes used here are
far too small for such an approach, and thus we instead reported Cohen’s d effect sizes [37]
in the pairwise contrast of the difference between the two groups for the continuous
measures and odds ratios for tests of designation as Sweet-dislikers. All effect sizes were
small or less-than-small, with the exception of sensitivity to sucrose, which yielded small-to-
medium effects, suggesting that the findings of non-significant differences should be
validated in larger samples.
Despite the limitation of small sample sizes, the patterns of data reported here reveal that
response profiles of both groups were highly similar. These preliminary findings suggest
that STT response profiles do not predict MDD status. This is in contrast to the utility of the
STT to predict alcoholism and genetic vulnerability to alcoholism [19,23]. These findings
constrain the diagnostic utility of the STT in unipolar MDD, and suggest that anhedonia in
MDD may not extend to sensory responses.
Acknowledgments
This research was supported by MH078145 to G. Dichter. M. Smoski was supported by NIMH T32-MH070448, a
NARSAD Young Investigator award, and a career development award from Duke University Medical Center,
NICHD K12 HD043446. G. Dichter was supported by Postdoctoral Research in Neurodevelopmental Disorders,
NICHD T32-HD40127, NARSAD Young Investigator awards, a career development award from UNC-Chapel
Hill, NIH/NCRR K12 RR023248, and NIMH K23 MH081285. We thank two anonymous reviewers for helpful
comments on a previous version of this manuscript.
References
1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV.
4. Washington, DC: 1994.
2. Sloan DM, Strauss ME, Quirk SW, Sajatovic M. Subjective and expressive emotional responses in
depression. Journal of Affective Disorders. 1997; 46:135–141. [PubMed: 9479617]
3. Sloan DM, Strauss ME, Wisner KL. Diminished response to pleasant stimuli by depressed women.
Journal of Abnormal Psychology. 2001; 110(3):488–493. [PubMed: 11502092]
4. Allen NB, Trinder J, Brennan C. Affective startle modulation in clinical depression: Preliminary
findings. Biological Psychiatry. 1999; 46(4):542–550. [PubMed: 10459405]
5. Rottenberg J, Gross JJ, Gotlib IH. Emotion context insensitivity in major depressive disorder.
Journal of Abnormal Psychology. 2005; 114(4):627–639. [PubMed: 16351385]
6. Dichter GS, Tomarken AJ, Shelton RC, Sutton SK. Early- and Late-Onset Startle Modulation in
Unipolar Depression. Psychophysiology. 2004; 41(3):433–440. [PubMed: 15102129]
Dichter et al. Page 6













7. Dichter GS, Tomarken AJ. The chronometry of affective startle modulation in unipolar depression. J
Abnorm Psychol. 2008; 117(1):1–15. [PubMed: 18266482]
8. Forbes EE, Hariri AR, Martin SL, Silk JS, Moyles DL, Fisher PM, et al. Altered Striatal Activation
Predicting Real-World Positive Affect in Adolescent Major Depressive Disorder. Am J Psychiatry.
2008
9. Knutson B, Bhanji JP, Cooney RE, Atlas LY, Gotlib IH. Neural responses to monetary incentives in
major depression. Biol Psychiatry. 2008; 63(7):686–692. [PubMed: 17916330]
10. Dichter GS, Felder JN, Petty C, Bizzell J, Ernst M, Smoski MJ. The Effects of Psychotherapy on
Neural Responses to Rewards in Major Depression. Biol Psychiatry. 2009
11. Lemke MR, Puhl P, Koethe N, Winkler T. Psychomotor retardation and anhedonia in depression.
Acta Psychiatr Scand. 1999; 99(4):252–256. [PubMed: 10223426]
12. Keedwell PA, Andrew C, Williams SC, Brammer MJ, Phillips ML. The neural correlates of
anhedonia in major depressive disorder. Biol Psychiatry. 2005; 58(11):843–853. [PubMed:
16043128]
13. Mitterschiffthaler MT, Kumari V, Malhi GS, Brown RG, Giampietro VP, Brammer MJ, et al.
Neural response to pleasant stimuli in anhedonia: an fMRI study. Neuroreport. 2003; 14(2):177–
182. [PubMed: 12598724]
14. Dichter GS, Felder JN, Petty C, Bizzell J, Ernst M, Smoski MJ. The effects of psychotherapy on
neural responses to rewards in major depression. Biol Psychiatry. 2009; 66(9):886–897. [PubMed:
19726030]
15. Pecina S, Smith KS, Berridge KC. Hedonic hot spots in the brain. Neuroscientist. 2006; 12(6):500–
511. [PubMed: 17079516]
16. Pecina S, Berridge KC. Hedonic hot spot in nucleus accumbens shell: where do mu-opioids cause
increased hedonic impact of sweetness? J Neurosci. 2005; 25(50):11777–11786. [PubMed:
16354936]
17. Smoski MJ, Felder J, Bizzell J, Green SR, Ernst M, Lynch TR, et al. fMRI of alterations in reward
selection, anticipation, and feedback in major depressive disorder. J Affect Disord. 2009
18. Kampov-Polevoy AB, Alterman A, Khalitov E, Garbutt JC. Sweet preference predicts mood
altering effect of and impaired control over eating sweet foods. Eat Behav. 2006; 7(3):181–187.
[PubMed: 16843219]
19. Kampov-Polevoy AB, Ziedonis D, Steinberg ML, Pinsky I, Krejci J, Eick C, et al. Association
between sweet preference and paternal history of alcoholism in psychiatric and substance abuse
patients. Alcohol Clin Exp Res. 2003; 27(12):1929–1936. [PubMed: 14691380]
20. Looy H, Weingarten HP. Effects of metabolic state on sweet taste reactivity in humans depend on
underlying hedonic response. Chemical Senses. 1991; 16:123–130.
21. Thompson DA, Moskowitz HR, Campbell RG. Effects of body weight and food intake on
pleasantness ratings for a sweet stimulus. J Appl Physiol. 1976; 41(1):77–83. [PubMed: 972136]
22. Drewnowski A, Greenwood MR. Cream and sugar: human preferences for high-fat foods. Physiol
Behav. 1983; 30(4):629–633. [PubMed: 6878464]
23. Kampov-Polevoy AB, Eick C, Boland G, Khalitov E, Crews FT. Sweet liking, novelty seeking,
and gender predict alcoholic status. Alcohol Clin Exp Res. 2004; 28(9):1291–1298. [PubMed:
15365298]
24. Berlin I, Givry-Steiner L, Lecrubier Y, Puech AJ. Measures of anhedonia and hedonic responses to
sucrose in depressive and schizophrenic patients in comparison with healthy subjects. Eur
Psychiatry. 1998; 13(6):303–309. [PubMed: 19698645]
25. Kazes M, Danion JM, Grange D, Pradignac A, Simon C, Burrus-Mehl F. Eating behaviour and
depression before and after antidepressant treatment: a prospective, naturalistic study. Journal of
Affective Disorders. 1994; 30:193–207. [PubMed: 8006246]
26. Amsterdam JD, Settle RG, Doty RL, Abelman E, Winokur A. Taste and smell perception in
depression. Biol Psychiatry. 1987; 22(12):1481–1485. [PubMed: 3676376]
27. First, MB.; Spitzer, RL.; Gibbon, M.; Williams, JBW. Structured Clinical Interview for DSM-IV
Axis I Disorders (SCID), Clinician Version; Administration Booklet. American Psychiatric Press;
Washington, D.C: 1996.
Dichter et al. Page 7













28. Hamilton MA. A rating scale for depression. Journal of Neurology and Neurosurgery in
Psychiatry. 1960; 23:56–62.
29. Blair JR, Spreen O. Predicting premorbid IQ: A revision of the national adult reading test. The
Clinical Neuropsychologist. 1989; 3:129–136.
30. Hopko DR, Lejuez CW, Ruggiero KJ, Eifert GH. Contemporary behavioral activation treatments
for depression: Procedures, principles, and progress. Clinical Psychology Review. 2003; 23:699–
717. [PubMed: 12971906]
31. Jacobson NS, Dobson KS, Truax PA, Addis ME, Koerner K, Gollan JK, et al. A component
analysis of cognitive-behavioral treatment for depression. J Consult Clin Psychol. 1996; 64(2):
295–304. [PubMed: 8871414]
32. Garbutt JC, Osborne M, Gallop R, Barkenbus J, Grace K, Cody M, et al. Sweet liking phenotype,
alcohol craving and response to naltrexone treatment in alcohol dependence. Alcohol Alcohol.
2009; 44(3):293–300. [PubMed: 19189996]
33. Wolfinger RD, O’Connell N. Generalized linear mixed models: a pseudolikelihood approach.
Journal of Statistical Computation and Simulation. 1993; 43:233–243.
34. Littell, RC.; Milliken, GA.; Stroup, WW.; Wolfinger, RD. SAS System for Mixed Models. Cary,
NC: SAS Institute Inc; 1995.
35. Durkalski VL, Palesch YY, Lipsitz SR, Rust PF. Analysis of clustered matched-pair data. Stat
Med. 2003; 22(15):2417–2428. [PubMed: 12872299]
36. Rosenthal JA. Qualitative descriptors of strength of association and effect size. J Soc Serv Res.
1996; 21:37–59.
37. Cohen, J. Statistical power analysis for the behavioral sciences. 2. Hillsdale, N.J: L. Erlbaum
Associates; 1988.
38. Price JL. Prefrontal cortical networks related to visceral function and mood. Ann N Y Acad Sci.
1999; 877:383–396. [PubMed: 10415660]
39. Berridge KC, Kringelbach ML. Affective neuroscience of pleasure: reward in humans and animals.
Psychopharmacology (Berl). 2008; 199(3):457–480. [PubMed: 18311558]
40. Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for
assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm. 1987; 15(6):657–
680. [PubMed: 3450848]
Dichter et al. Page 8
Depress Anxiety. Author manuscript; available in PMC 2011 September 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
